SC 13G

Company

Cogent Biosciences, Inc.

Filed

March 1, 2022

Accession Number

0001193125-22-061021

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →